Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 19, 2019 - Issue 8: Special Focussed Issue on Migraine
Submit an article Journal homepage
296
Views
12
CrossRef citations to date
0
Altmetric
Drug Profile

Fremanezumab as a preventive treatment for episodic and chronic migraine

Marcelo E. BigalPurdue Pharma, Stamford, CT, USACorrespondence[email protected]
View further author information
,
Sarah WalterAntiva Biosciences, San Francisco, CA, USAView further author information
&
Alan M. RapoportDepartment of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USAView further author information
Pages 719-728 | Received 30 Jan 2019, Accepted 30 Apr 2019, Published online: 22 May 2019

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.